Jim Cramer: Buy This Energy Stock, It Is ‘Terrific’
Cramer favored ET, PANW and CRWD over SentinelOne, advised waiting on Corning, called GEMI speculative, and supported holding Aveanna.
Stocks · News reference
Inspire Medical, Cybin and Aveanna show overbought RSI readings above 70, signaling potential momentum warnings for healthcare investors.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Cramer favored ET, PANW and CRWD over SentinelOne, advised waiting on Corning, called GEMI speculative, and supported holding Aveanna.
JP Morgan analyst Benjamin Rossi maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to $15.
Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and raises the price target from $9.5 to $15.
TD Cowen analyst Ritu Baral maintains Helus Pharma (NASDAQ:HELP) with a Buy and raises the price target from $8 to $62.
Helus Pharma (NASDAQ:HELP) reported quarterly losses of $(0.91) per share which beat the analyst consensus estimate of $(1.07) by 14.95 percent. This is a 17.27 percent increase over losses of $(1.10) per share from the
Summary: U.S. stock futures mixed, Dow futures down 0.1%. AirSculpt Technologies shares fell 13.4% after reporting Q2 results in-line with estimates. Other stocks moving lower in pre-market trading include NAMI, BNED, YXT, TENX, MSC, B, VRSK, XFOR, HELP, and SLDB.